Casdin Capital LLC 13D/13G Filings for BioLife Solutions, Inc. (BLFS)

Casdin Capital LLC 13D and 13G filings for BioLife Solutions, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-06-04
6:36 pm
Unchanged
2026-06-0413GBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC4,757,165
9.700%
0
(Unchanged)
Filing
2026-05-22
6:37 pm
Sale
2026-05-2013DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC4,757,165
9.700%
-1,200,000decrease
(-20.14%)
Filing
2025-10-17
8:04 pm
Sale
2025-10-1513DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC5,957,165
12.400%
-750,000decrease
(-11.18%)
Filing
2025-08-21
9:35 pm
Sale
2025-08-1513DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC6,707,165
14.000%
-500,000decrease
(-6.94%)
Filing
2025-08-13
7:00 pm
Sale
2025-08-1113DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC7,207,165
15.000%
-500,000decrease
(-6.49%)
Filing
2025-06-12
9:10 pm
Sale
2025-06-1013DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC7,707,165
16.200%
-1,027,994decrease
(-11.77%)
Filing
2025-04-09
5:13 pm
Purchase
2025-04-0713DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC8,735,159
18.500%
27,994increase
(+0.32%)
Filing
2023-10-24
4:29 pm
Purchase
2023-10-1913DBIOLIFE SOLUTIONS INC
BLFS
Casdin Capital LLC8,707,165
19.500%
5,361,130increase
(+160.22%)
Filing